FDA’s Advisory Committee Conflict of Interest Policy Too Restrictive, Nissen Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Cleveland Clinic cardiologist says FDA conflict of interest guidelines would prevent him from a second term on an advisory committee.